Navigation Links
Wolters Kluwer Research Now Available via Bloomberg Tradebook
Date:11/10/2011

PHOENIX, Nov. 10, 2011 /PRNewswire/ -- Wolters Kluwer Pharma Solutions, a leading provider of scientific information and analytics, is providing its industry research and analytics to investors through Bloomberg Tradebook's Independent Research Provider (IRP) offering.  The distribution is managed by inThought™, Wolters Kluwer Pharma Solutions' research and consulting business, which specializes in forward-looking analyses of pharmaceutical drugs and medical devices.

Led by a team of industry veterans with extensive sell-side research experience, inThought delivers actionable market research reports read by pharmaceutical and healthcare professionals worldwide.  The same research, insights and analytics are now available to Bloomberg Tradebook clients as of today.

"We're looking to partner with independent research providers as a means to differentiate Bloomberg Tradebook from other agency brokers," said Ray Tierney, President and CEO of Bloomberg Tradebook.  "InThought is known for publishing independent and informed market analysis that Bloomberg Tradebook customers can use to develop smart trading strategies."

Bloomberg Professional service subscribers have been able to access a variety of research materials from Wolters Kluwer Pharma Solutions in the past, including Source® U.S. prescription data and the Adis R&D Insight™ drug pipeline database.  Now, Bloomberg Tradebook customers can access these research tools and services plus regular research updates, company pipeline reports, drug and device revenue models, and custom data pulls from the Adis R&D Insight and Source databases that include information such as prescriber specialty, co-pay amount, and insurance rejection rate for U.S. pharmaceutical products. In addition, Bloomberg Tradebook customers can ask the inThought team to answer questions and discuss drug and medical device companies.

"Given the complexities of drug pipeline data involving pharmaceutical manufacturers, insurance companies, doctors, and patients, it is natural for Bloomberg Tradebook customers to seek deeper and actionable insight from the Wolters Kluwer data," said Ben Weintraub, Director of Research, inThought.  "We are excited to work with Bloomberg Tradebook to create an end-to-end solution for investors interested in the healthcare sector."

Access to inThought research is available immediately for Bloomberg Tradebook clients with a research trading account at {TBR<GO>}.  Information is also available online at the Bloomberg Tradebook website at www.bloombergtradebook.com and the Wolters Kluwer Pharma Solutions homepage at www.wolterskluwerpharma.com.

About Wolters Kluwer Pharma Solutions

Wolters Kluwer Pharma Solutions, Inc. (Phoenix, AZ and Yardley, PA) is a leading provider of information and analytics to the pharmaceutical, biotech, and medical device industries. The company's brands include Adis, Source® and Lippincott Williams & Wilkins. A provider of business intelligence and services, Adis publishes more than 40 peer-reviewed publications in the area of pharmacology and offers the most respected drug and clinical trials databases in the pharma industry. Lippincott Williams & Wilkins (LWW) is a leading international healthcare publisher with nearly 300 periodicals and 1,500 books in more than 100 disciplines. A longstanding provider of market data and healthcare analytics, Source® offers a unique set of comprehensive patient and physician-level prescribing and usage data. For more information, visit www.wolterskluwerpharma.com.

Wolters Kluwer Pharma Solutions is a part of Wolters Kluwer, a market-leading global information services company with 2010 annual revenues of euro 3.6 billion ($4.7 billion).

Contact: Tom Kivett
Kivett & Company Communications
(212) 727-2935
tkivett@kivettandco.com


'/>"/>
SOURCE Wolters Kluwer Pharma Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Biochemistry and Bioengineering Research Brings California Students Closer to Nations Highest Science Honor for High School Students
2. Researchers roll out a new form of lighting
3. University of Toronto researchers create worlds most efficient flexible OLED on plastic
4. Research: Graphene grows better on certain copper crystals
5. Immune Design Corp. and Sanofi-Aventis Announce Research Collaboration
6. Reprints Desk and Deep Web Technologies Announce Agreement to Integrate Research Services
7. New England Research Institutes (NERI) Announces Additional $45M NIH Grant to Support the Pediatric Heart Network
8. Cord Blood America Provides Insight on Worldwide Research Using Umbilical Cord Blood Stem Cells to Treat Numerous Diseases
9. Congressman Eric Cantor and Health Diagnostic Laboratory, Inc. Discuss Job Growth at Virginia BioTechnology Research Park
10. Pharmatech Oncology Announces Completion of SBIR Grant Research
11. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... Orleans, La. (PRWEB) , ... March 23, 2017 ... ... real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd ... APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career ...
(Date:3/22/2017)... , March 22, 2017 Good Start Genetics, ... has eclipsed the 130 million covered lives mark through ... of Texas . With newly signed ... continues to enjoy strong payor acceptance based on the ... programs and genetic counseling, its industry-leading customer care and ...
(Date:3/22/2017)... - FACIT announced a seed stage investment in ... created by FACIT focused on developing a portfolio ... non-dilutive capital, achieves a targeted $3.0M financing for ... to accelerate the nomination of a candidate drug ... a strategic partnership for clinical trials in patients ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
Breaking Biology News(10 mins):